Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Tumentia Research

Request full access

Dementia research, diagnosis, and treatment access.

Casper, United StatesFounded 2014Biotech & Life Sciences

About Tumentia Research

Tumentia Research, also operating as the Dementia Studies Foundation, is a 501(c)(3) non-profit organization dedicated to addressing Alzheimer's and Dementia. The foundation's core mission is to remove barriers to dementia research, diagnosis, and treatment for all communities. They aim to build trust, empower individuals, and promote inclusive, evidence-based approaches to brain health.

Operating from Athens, Texas, the organization works towards a future focused on finding a cure for Alzheimer's and Dementia. It provides a platform for solutions targeted at pharmaceutical companies, medical device manufacturers, and healthcare providers. Their services appear to encompass regulatory submissions, data management, clinical trial management, and medical writing, suggesting a role as a contract research organization or a similar entity supporting clinical research.

The broader context of their work is the growing public health concern of dementia, which is the seventh leading cause of death globally and a major source of disability among older adults. Research in this field, which Tumentia supports, involves investigating lifestyle interventions, genetic factors, and disease pathways to develop biomarkers for early detection and new treatments. The ultimate goal is to translate scientific knowledge into effective prevention and treatment strategies for diseases like Alzheimer's, which is the most common form of dementia.

Source: Dealroom company data

At a glance

Status
Acquired
Founded
2014
Headquarters
Casper, United States
Open positions
None listed
Dealroom signal
19.0/100
Industry
Health
Sub-industry
Pharmaceutical
Sector
Biotech & Life Sciences, Biotechnology, Oncology, Verified Unicorns and $1B Exits, Biotech and Pharma, DT and LS, science-based
Business model
Manufacturing
Client focus
B2B
Links
Website

Funding history

2 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
ACQUISITIONOther financing Oct 2017 $1.2B $1.2B Excellence Health —
SERIES AOther financing Jan 2015 $60M $240M Undisclosed —
Showing the latest 2 of 2 recorded eventsBook a demo for the full funding history →

Growth signals

Tumentia Research website traffic

Latest recorded traffic for Tumentia Research is 0 monthly website visits.

Latest monthly visits0
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Tumentia Research in the Casper ecosystem

Live from Dealroom

The Tumentia Research office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

1 investor on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Other known investors1 additional known investor

  • Excellence Health
Founders Hidden — book a demo/100 quality score
Key operators Hidden — book a demo quality score
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
🇺🇸 United States · Casper HQ
Book a demo for the full country breakdown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Tumentia Research on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Tumentia Research’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.